SAMUEL TIU is an accomplished IP litigator in the areas of patents and trade secrets. Sam has litigated IP cases in a wide variety of technologies including industrial and chemical processes, solar and laser technologies, nanotechnology, medical devices, pharmaceuticals, biotechnology, computer animation and graphics, video and data transmission, network technology and video display technology.
- Amgen v. Sandoz (D.N.J.) – Successfully tried and obtained a permanent injunction for Amgen in the biotech industry’s first major biosimilar litigation with Sandoz, thus protecting Amgen’s rights to its blockbuster rheumatoid arthritis biopharmaceutical.
- Hanwha v. LONGi Solar Technology – Represented LONGi Solar in its defense against Hanwha’s patents relating to solar cell composition and manufacture in the ITC and PTAB and secured a finding of non-infringement (ITC) and patent invalidity (PTAB); both affirmed on appeal.
- Spine Solutions, Inc. v. Medtronic Sofamor Danek (W.D. Tenn.) – Successfully tried and secured a jury verdict of infringement and validity for Synthes and Spine Solutions (now part of Johnson & Johnson) for a patent relating to spinal disc replacement, and obtained entry of a permanent injunction against Medtronic Sofamor Danek’s lumbar artificial disc products. The jury verdict of validity and 18% royalty was upheld on appeal.
Sam is admitted to practice before the U.S. Patent and Trademark Office and also counsels clients on various aspects of intellectual property, including intellectual property procurement strategies, licensing, and due diligence. Managing Intellectual Property named Sam a “Patent Star” for 2019, 2021, and 2022. Before starting his legal career, Sam worked in the biotechnology industry for seven years. He has a technical background in microbiology and molecular genetics, and he is also fluent in Chinese.